April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
ASCO’s new living guideline update for Stage IV NSCLC with Driver Alterations
Mar 3, 2025, 10:24

ASCO’s new living guideline update for Stage IV NSCLC with Driver Alterations

American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:

“The American Society of Clinical Oncology’s (ASCO) new living guideline update, Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations, is now available.

Updated recommendations include that clinicians can now consider osimertinib combined with platinum-based chemotherapy or the combination of amivantamab and lazertinib as potential treatment options.

Read more.”

ASCO's new living guideline update for Stage IV NSCLC with Driver Alterations